Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-060145
Filing Date
2020-05-12
Accepted
2020-05-12 16:01:14
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014492d1_10q.htm 10-Q 702995
2 EXHIBIT 31.1 tm2014492d1_ex31-1.htm EX-31.1 9194
3 EXHIBIT 31.2 tm2014492d1_ex31-2.htm EX-31.2 8972
4 EXHIBIT 32.1 tm2014492d1_ex32-1.htm EX-32.1 4446
  Complete submission text file 0001104659-20-060145.txt   4070151

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20200331.xml EX-101.INS 1024232
6 XBRL TAXONOMY EXTENSION SCHEMA catb-20200331.xsd EX-101.SCH 32134
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE catb-20200331_cal.xml EX-101.CAL 38339
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE catb-20200331_def.xml EX-101.DEF 87243
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE catb-20200331_lab.xml EX-101.LAB 306506
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE catb-20200331_pre.xml EX-101.PRE 203473
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 20868975
SIC: 2834 Pharmaceutical Preparations